The pharmacokinetics of prednisolone were determined in 12 patients with oral vesiculo-erosive diseases. The bioavailability of prednisone in these patients exhibited a low intersubject variability, while the metabolic clearance rate of total and of unbound prednisolone varied considerably from patient to patient.
Get full access to this article
View all access options for this article.
References
1.
Lozada, F. and Silverman, S., Jr.: Erythema Multiforme : Clinical Characteristics and Natural History in 50 Patients, Oral Surg46:628-6 36, 1978.
2.
Lozada, F. and Silverman, S., Jr.: Lidex (Fluocinonide) in Orabase for Oral Vesiculoerosive Diseases, Arch Derm116: 898-901, 1980.
3.
Fellner, M.U. ; Katz, U.M.; and McCabe , U.B.: Successful Use of Cyclophosphamide and Prednisone for Initial Treatment of Pemphigus Vulgaris , Arch Dermatol114:889-894, 1978.
4.
Moschella, S. : Chemotherapy Used in Dermatology, Cutis19:603-605, 609-611, 1977.
5.
Lozada, F.: Prednisone and Azathioprine in the Treatment of Oral Inflammatory Disease , Oral Surg52:257-260, 1981.
6.
Van Dijk, T.J.A. and Van Velde, J.L.: Treatment of Pemphigus and Pemphigoid with Azathioprine, Dermatologica147: 179-185, 1973.
7.
McClatchey, K.D.; Silverman, S., Jr.; and Hansen , L.: Studies on Lichen Planus: III. Clinical and Histologic Correlations in 213 Patients, Oral Surg39(1):122-129, 1975.
8.
Griffith, M. ; Fukuyama, K.; Tuffanelli , D.; and Silverman, S., Jr.: Immunofluorescence Studies in Mucous Membrane Pemphigoid, Arch Dermatol109:195-199, 1974.
9.
Olson, J.; Greenspan, J.S.; and Silverman, S., Jr.: Recurrent Aphthous Stomatitis: Current Status of Etiology and Treatment, J CA Dent Assoc10:53-57, 1982.
10.
Frey, F.J.; Frey, B.M.; and Benet, L.Z.: Liquid Chromatographic Measurements of Edogenous and Exogenous Glucocorticoids in Plasma, Clin Chem25:1944-1947, 1979 .
11.
Frey, F.J.; Frey, B.M.; Greither, A.; and Benet, L.Z.: Prednisone Clearance at Steady-state in Dogs, J Pharmacol Exp Ther215(2):287-291, 1980.
12.
Gibaldi, M. and Perrier, D.: Trapezoidal Rule. In: Pharmacokinetics, Swarbrick, J., Ed., New York: Marcel Dekker, Inc., 1975, pp. 293-296.
13.
Benet, L.Z. and Galeazzi, R.L.: Noncompartmental Determination of the Steady-state Volume of Distribution, J Pharm Sci68:1071-1074, 1979.
14.
Frey, F.J.; Lozada, F.; Guentert, T.; and Frey, B.M.: A Single Dose of Azathioprine does not Affect the Pharmacokinetics of Prednisolone Following Oral Prednisone, Eur J Clin Pharmacol19:209-219, 1981.
15.
Jusko, W.J.: Pharmacokinetics in Disease States Changing Protein Binding. In: The Effect of Disease States on Drug Pharmacokinetics, Benet, L.Z., Ed., American Pharmaceutical Association, Academy of Pharmaceutical Sciences, 1976, pp. 99-123.
16.
Levy, G.; Hall, N.A.; and Nelson, E.: Studies on Active Prednisone Tablets USP XVI, Am J Hosp Pharm21:402, 1964.
17.
Kozower, M. ; Veatch, L.; and Kaplan, M.M.: Decreased Clearance of Prednisolone, a Factor in the Development of Corticosteroid Side Effects, J Clin Endocrinol Metab38 :407-412, 1974.
